Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell - 9-MTH group results

Feb 9 (Reuters)- 
             Reprocell Incorporated 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               1.78                2.22             3.05     
                   (-20.1 pct)         (+49.4 pct)      (+3.2 pct)  
  Operating       loss 289 mln        loss 207 mln     loss 110 mln 
  Recurring          58 mln            loss 36 mln        148 mln   
  Net                48 mln            loss 39 mln        148 mln   
  EPS               0.57 yen          loss 0.47 yen      1.74 yen   
  EPS Diluted       0.57 yen                                        
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - Reprocell Incorporated. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news